Burden of disease in US patients with skeletal versus muscular or pain manifestations of hypophosphatasia: An analysis from the Global HPP Registry
Open Access
Abstract
No abstract availableKeywords
Funding Information
- AstraZeneca
This publication has 28 references indexed in Scilit:
- Revisiting the Genetics of HypophosphatasiaJournal of Inherited Metabolic Disease, 2025
- New insights into the landscape of ALPL gene variants in patients with hypophosphatasia from the Global HPP RegistryAmerican Journal of Medical Genetics Part A, 2024
- A Delphi panel to build consensus on assessing disease severity and disease progression in adult patients with hypophosphatasia in the United StatesJournal of Endocrinological Investigation, 2024
- Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adultsOsteoporosis International, 2023
- Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working GroupOsteoporosis International, 2023
- The challenge of hypophosphatasia diagnosis in adults: results from the HPP International Working Group Literature SurveillanceOsteoporosis International, 2023
- Not just a carrier: Clinical presentation and management of patients with heterozygous disease‐causing alkaline phosphatase (ALPL) variants identified through expanded carrier screeningMolecular Genetics & Genomic Medicine, 2022
- Physical Function and Health‐Related Quality of Life in Adults Treated With Asfotase Alfa for Pediatric‐Onset HypophosphatasiaJBMR Plus, 2020
- Reliability and Validity of the 6‐Minute Walk Test in HypophosphatasiaJBMR Plus, 2018
- Neurological symptoms in HypophosphatasiaOsteoporosis International, 2018